Orchid Pharma Ltd. benchmarking: Performance to industry peers

Financial

	Orchid Pharma	Guj. Themis Biosyn	Novartis
Operational Metrics
Financials
5 yr Average ROE	4.49 %	34.65 %	8.11 %
5yr average Equity Multiplier	1.61	1.29	2.72
5yr Average Asset Turnover Ratio	0.5	0.74	0.18
5yr Avg Net Profit Margin	0.56 %	35.51 %	17.12 %
Price to Book	2.82	14.92	3.8
P/E	190.27	82.58	33.36
5yr Avg Cash Conversion Cycle	52.03 Days	-112.39 Days	-23.33 Days
Inventory Days	112.47 Days	22.82 Days	44.27 Days
Days Receivable	86.58 Days	70.51 Days	38.18 Days
Days Payable	159.29 Days	130.88 Days	124.28 Days
5yr Average Interest Coverage Ratio	3.01	216.76	65.43
5yr Avg ROCE	3.08 %	45.66 %	5.91 %
5yr Avg Operating Profit Margin	11.84 %	47.34 %	15.15 %
5 yr average Debt to Equity	0.37	0.03	0.0
5yr CAGR Net Profit	n/a	10.07 %	37.01 %
5yr Average Return on Assets	1.2 %	26.69 %	3.13 %
Shareholdings
Promoter Holding	69.84 %	70.86 %	70.68 %
Share Pledged by Promoters	0.0	5.44 %	0.0
Change in Promoter Holding (3 Yrs)	-20.12 %	-4.13 %	0.0
Change in Mutual Fund Holding (3 Yrs)	16.98 %	1.14 %	0.0

	Orchid Pharma	Guj. Themis Biosyn	Novartis
Product Wise Break-Up	Product Wise Break-Up Oral Formulations 72.44 Sterile 27.56 0 0	Product Wise Break-Up 0 Sterile 0 Pharmaceutical 100.0 Oral Formulations 0	Product Wise Break-Up Wholesale of pharmaceuticals and medical goods 100.0 Sterile 0 0 Oral Formulations 0
Location Wise Break-Up	Location Wise Break-Up India 19.9 Others 80.1	-	Location Wise Break-Up India 100.0
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise Others 100	-	-